Griselda Ma. Chávez-Camarillo

Dr. Griselda Ma. Chávez-Camarillo


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2018 in Annals of Microbiology
Verified
Journal Article
Closed access
PDF file
GCGriselda Ma. Chávez-Camarillo
Griselda Ma. Chávez-Camarillo
USUriel Mauricio Santiago-Flores
Uriel Mauricio Santiago-Flores
AMArmando Mena-Vivanco
Armando Mena-Vivanco
LMLiliana Morales-Barrera
Liliana Morales-Barrera
ECElias Cortés-Acosta
Elias Cortés-Acosta
Eliseo Cristiani-UrbinaEliseo Cristiani-Urbina
Eliseo Cristiani-Urbina

7 May 2023 in Fermentation
Verified
Journal Article
Open access
PDF file
Alejandro Pérez-RodríguezAlejandro Pérez-Rodríguez
Alejandro Pérez-Rodríguez
CFCesar Flores
Cesar Flores
GCGriselda Ma. Chávez-Camarillo
Griselda Ma. Chávez-Camarillo
Eliseo Cristiani-UrbinaEliseo Cristiani-Urbina
Eliseo Cristiani-Urbina
Liliana Morales-BarreraLiliana Morales-Barrera
Liliana Morales-Barrera
Oleic acid is increasingly required in many industries, causing the indiscriminate extension of land for the cultivation of certain agricultural products to extract their oil. The current contribution aimed to cultivate Candida wangnamkhiaoensis (CW) for the production of lipids and determine the profile of fatty acids in these lipids. The lipid yield was compared in the yeast when using glucose or glycerol as the substrate, in both cases being over 24%. The main fatty acids in the oil derived from CW were oleic, palmitic, stearic, and linoleic acid. The fatty acid composition of the oil from CW was very similar to that of avocado oil and resembled that of olive oil and palm oil. The advantages of cultivating CW include its relatively high percentage of oleic acid and the balance of other fatty acids, its capacity to generate lipids in a short time (48–72 h), the controlled environment of production (versus the variability of the cultivation of agricultural products), and the relatively limited surface area required. CW shows potential as an alternative and economical source of oleic acid for the food, drug, cosmetics, lubricant, and biofuel industries, and does not require the alteration of large extensions of land.

2 February 2026 in World Journal of Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
Raziel Arturo Jiménez-NavaRaziel Arturo Jiménez-Nava
Raziel Arturo Jiménez-Nava
GCGriselda Ma. Chávez-Camarillo
Griselda Ma. Chávez-Camarillo
Eliseo Cristiani-UrbinaEliseo Cristiani-Urbina
Eliseo Cristiani-Urbina

3 April 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
Raziel Arturo Jiménez-NavaRaziel Arturo Jiménez-Nava
Raziel Arturo Jiménez-Nava
GCGriselda Ma. Chávez-Camarillo
Griselda Ma. Chávez-Camarillo
Eliseo Cristiani-UrbinaEliseo Cristiani-Urbina
Eliseo Cristiani-Urbina
Riboflavin is biosynthesized and excreted extracellularly by the novel yeast Hyphopichia wangnamkhiaoensis. The steady-state kinetics of cell growth, substrate consumption, and riboflavin production by H. wangnamkhiaoensis were studied in a chemostat continuous culture at different dilution rates. The unstructured Monod and Luedeking–Piret models were used to describe cell growth, substrate consumption, and riboflavin production, and crucial kinetic parameters were estimated. The experimental data fitted the proposed models well. The maximum specific growth rate, substrate affinity constant, maintenance energy coefficient, and maximum biomass yield values were 0.1378 h−1, 0.4166 g of glucose L−1, 0.1047 g of glucose g−1 of biomass h−1, and 0.172 g of biomass g−1 of glucose, respectively. The maximum yield from glucose and volumetric and specific productivities of riboflavin were 0.7487 mg of riboflavin g−1 of glucose, 0.5593 mg of riboflavin L−1 h−1, and 0.6547 mg of riboflavin g−1 of biomass h−1, respectively. The estimated growth-associated riboflavin production constant (4.88 mg of riboflavin g−1 of biomass) was much higher than the non-growth-associated riboflavin production constant (0.0022 mg of riboflavin g−1 of biomass h−1), indicating that riboflavin production by H. wangnamkhiaoensis is a predominantly growth-associated process. The chemostat continuous culture offers a promising strategy for efficiently and sustainably producing riboflavin using H. wangnamkhiaoensis.

28 February 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Raziel Arturo Jiménez-NavaRaziel Arturo Jiménez-Nava
Raziel Arturo Jiménez-Nava
GCGriselda Ma. Chávez-Camarillo
Griselda Ma. Chávez-Camarillo
Eliseo Cristiani-UrbinaEliseo Cristiani-Urbina
Eliseo Cristiani-Urbina
Riboflavin (RF; vitamin B2) is an essential micronutrient with broad applications in the food, feed, pharmaceutical, and cosmetic industries and is increasingly relevant in bioelectrochemical systems and environmental biotechnology. Microbial fermentation has replaced chemical synthesis as the dominant industrial production route due to its superior sustainability and scalability. However, despite substantial progress, RF biosynthesis remains constrained by imbalances in precursor supply, complex redox regulation, and regulatory feedback mechanisms that limit metabolic flux toward guanosine triphosphate and ribulose-5-phosphate. This review provides an updated, integrative analysis of RF biotechnology, encompassing biosynthetic pathways, transcriptional and redox-regulation, strain improvement strategies, and fermentation process optimization. Representative industrial producers—including Bacillus subtilis, Ashbya gossypii, and Candida famata—are critically evaluated for productivity, yield, and metabolic robustness, with reported titers reaching up to 29 g L−1 in engineered systems. Emerging microbial platforms, including lactic acid bacteria, thermotolerant and methylotrophic microorganisms, and electroactive bacteria, are discussed in the context of niche applications such as food biofortification and microbial fuel cells. Special emphasis is placed on oxidative stress as a regulatory signal influencing RF overproduction, metabolic rewiring strategies to alleviate precursor bottlenecks, and the biosynthesis of RF derivatives (FMN, FAD, roseoflavin, and 8-aminoriboflavin). In addition, biosafety, regulatory constraints, concerns about genome stability, and antibiotic-free engineering approaches are examined as critical determinants of future industrial competitiveness. By integrating molecular regulation, metabolic engineering, fermentation design, emerging applications, and regulatory perspectives within a unified framework, this review outlines current bottlenecks and future directions for developing safer, more robust, and economically competitive RF-producing microbial platforms.